+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
ARISTO

Aristo Bio-Tech and Lifescience Share Price

 

 

Aristo Bio-Tech and Lifescience live price: ₹99.7. It opened at ₹95 vs previous close ₹95; intraday high/low: ₹100/₹95. The 50 & 200 DMA stand at ₹102.03/₹111.68.

Aristo Bio-Tech and Lifescience Performance

  • Today's Low
  • ₹95
  • Today's High
  • ₹100
  • 52 Week Low
  • ₹74
  • 52 Week High
  • ₹144
  • Open Price₹95
  • Previous Close₹95
  • Volume1,600
  • 50 DMA₹102.03
  • 100 DMA₹107.25
  • 200 DMA₹111.68

Aristo Bio-Tech and Lifescience Chart

Investment Returns

  • Over 1 Month -13.72%
  • Over 3 Month + 20.12%
  • Over 6 Month -16.67%
  • Over 1 Year -15.4%

Smart Investing Starts Here Start SIP with Aristo Bio-Tech and Lifescience for Steady Growth!

Invest Now

Aristo Bio-Tech and Lifescience Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 9.4
  • PEG Ratio
  • -
  • Market Cap Cr
  • 68
  • P/B Ratio
  • 1.5
  • Average True Range
  • 3.9
  • EPS
  • 10.55
  • Dividend Yield
  • 0.5
  • MACD Signal
  • -0.26
  • RSI
  • 49.27
  • MFI
  • 31.05

Aristo Bio-Tech and Lifescience Financials

Aristo Bio-Tech and Lifescience Technicals

EMA & SMA

Current Price
₹99.70
+ 4.65 (4.89%)
pointer
  • Bearish Moving Average 10
  • Bullish Moving Average 6
  • 20 Day
  • ₹99.90
  • 50 Day
  • ₹102.00
  • 100 Day
  • ₹107.20
  • 200 Day
  • ₹111.70

Resistance and Support

98.22 Pivot Speed
  • R3 105.63
  • R2 102.67
  • R1 101.18
  • S1 96.73
  • S2 93.77
  • S3 92.28

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Aristo Bio-Tech And Lifescience has an operating revenue of Rs. 681.81 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 3% needs improvement, ROE of 16% is good. The company has a reasonable debt to equity of 17%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 200DMA and close to its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 34 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 136 indicates it belongs to a poor industry group of Chemicals-Agricultural and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Aristo Bio-Tech and Lifescience Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-30 Audited Results, Dividend & Others To consider other business matters. (Revised) Final Dividend of Rs. 0.5 per equity share.
2025-11-14 Quarterly Results & Others To consider other business matters. Final Dividend of Rs. 0.5 per equity share.
2025-05-29 Audited Results, Dividend & Others To consider other business matters. Final Dividend of Rs. 0.5 per equity share.
2024-11-13 Quarterly Results & Others To consider other business matters. Final Dividend of Rs. 0.5 per equity share.
2024-05-27 Audited Results & Dividend
Date Purpose Remarks
2025-09-01 FINAL Rs.0.00 Final Dividend of Rs. 0.5 per equity share.
2024-09-13 FINAL Recommended Final Dividend of 0.4 per equity share. Final Dividend of Rs. 0.5 per equity share.
2023-09-15 FINAL Recommended Final Dividend of 0.25 per equity share Final Dividend of Rs. 0.5 per equity share.
View Aristo Bio-Tech and Lifescience Dividend History Arrow

Aristo Bio-Tech and Lifescience Shareholding Pattern

73.42%
24.28%
2.3%

Aristo Bio-Tech and Lifescience FAQs

Aristo Bio-Tech and Lifescience share price is ₹99 As on 24 June, 2026 | 06:30

The Market Cap of Aristo Bio-Tech and Lifescience is ₹67.9 Cr As on 24 June, 2026 | 06:30

The P/E ratio of Aristo Bio-Tech and Lifescience is 9.4 As on 24 June, 2026 | 06:30

The PB ratio of Aristo Bio-Tech and Lifescience is 1.5 As on 24 June, 2026 | 06:30

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23